Yongchen Hao

1.5k total citations
59 papers, 812 citations indexed

About

Yongchen Hao is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Yongchen Hao has authored 59 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Surgery. Recurrent topics in Yongchen Hao's work include Acute Myocardial Infarction Research (27 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers) and Atrial Fibrillation Management and Outcomes (11 papers). Yongchen Hao is often cited by papers focused on Acute Myocardial Infarction Research (27 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers) and Atrial Fibrillation Management and Outcomes (11 papers). Yongchen Hao collaborates with scholars based in China, United States and Australia. Yongchen Hao's co-authors include Dong Zhao, Jing Liu, Yong Huo, Gregg C. Fonarow, Sidney C. Smith, Kathryn A. Taubert, Changsheng Ma, Louise Morgan, Jun Liu and Yue Qi and has published in prestigious journals such as Circulation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Yongchen Hao

54 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yongchen Hao China	14	547	205	135	104	89	59	812
Chike C. Nwabuo United States	18	512 0.9×	78 0.4×	143 1.1×	123 1.2×	98 1.1×	40	846
Renato Quispe United States	13	269 0.5×	234 1.1×	202 1.5×	65 0.6×	98 1.1×	36	641
Donald Clark United States	13	389 0.7×	201 1.0×	177 1.3×	57 0.5×	62 0.7×	36	655
Dayi Hu China	14	460 0.8×	166 0.8×	160 1.2×	78 0.8×	109 1.2×	70	823
Karl Andersen Iceland	16	729 1.3×	196 1.0×	275 2.0×	175 1.7×	57 0.6×	79	1.0k
Ömer Kozan Türkiye	16	622 1.1×	210 1.0×	165 1.2×	129 1.2×	62 0.7×	74	1.0k
Milika Ašanin Serbia	20	878 1.6×	299 1.5×	122 0.9×	276 2.7×	44 0.5×	104	1.2k
Yihong Sun China	14	421 0.8×	188 0.9×	117 0.9×	49 0.5×	35 0.4×	76	733
Lynn A. Smaha United States	8	414 0.8×	181 0.9×	106 0.8×	134 1.3×	88 1.0×	15	802
Icilma Fergus United States	11	352 0.6×	148 0.7×	96 0.7×	56 0.5×	30 0.3×	24	598

Countries citing papers authored by Yongchen Hao

Since Specialization

Citations

This map shows the geographic impact of Yongchen Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongchen Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongchen Hao more than expected).

Fields of papers citing papers by Yongchen Hao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongchen Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongchen Hao. The network helps show where Yongchen Hao may publish in the future.

Co-authorship network of co-authors of Yongchen Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Yongchen Hao. A scholar is included among the top collaborators of Yongchen Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongchen Hao. Yongchen Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Yang, Pan Zhou, Fangfang Fan, et al.. (2025). A simple score, CKM2S2-BAG, to predict cardiovascular risk with cardiovascular-kidney-metabolic health metrics. iScience. 28(7). 112780–112780.

Hao, Yongchen, Jun Liu, Na Yang, et al.. (2025). Blood pressure and in-hospital outcomes in patients hospitalized with atrial fibrillation: findings from the CCC-AF project. Hypertension Research. 48(4). 1331–1341.

Zhang, Yuxin, Zhaoji Li, & Yongchen Hao. (2025). Comparative efficacy of GLP-1 RAs/SGLT-2 inhibitors in reducing cardiovascular events in type 2 diabetes according to baseline use of metformin: a systematic review and meta-analysis of randomized controlled trials. European journal of medical research. 30(1). 13–13. 2 indexed citations

Xu, Shuwan, Jun Liu, Dong Zhao, et al.. (2024). The association between the AIP and undiagnosed diabetes in ACS patients with different body mass indexes and LDL-C levels: findings from the CCC-ACS project. Cardiovascular Diabetology. 23(1). 77–77. 8 indexed citations

Li, Zhi, Haonan Sun, Yongchen Hao, et al.. (2023). Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health record-based cohort in China. European Heart Journal - Quality of Care and Clinical Outcomes. 9(8). 785–795. 4 indexed citations

Zhao, Dong, Jiayi Sun, Jun Liu, et al.. (2023). Lipoprotein(a) Is Associated With the Progression and Vulnerability of New-Onset Carotid Atherosclerotic Plaque. Stroke. 54(5). 1312–1319. 10 indexed citations

He, Pengkang, Jie Jiang, Fangfang Fan, et al.. (2023). In-hospital therapies and determinants of treatment strategy selection in patients with atrial fibrillation and left ventricular systolic dysfunction in China: a retrospective study based on the Improving Care for Cardiovascular Disease in China-Atrial Fibrillation (CCC-AF) project, 2015–2019. BMJ Open. 13(6). e070070–e070070. 1 indexed citations

Zhou, Mengge, Jie Zhang, Jing Liu, et al.. (2022). Proton Pump Inhibitors and In-Hospital Gastrointestinal Bleeding in Patients With Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy. Mayo Clinic Proceedings. 97(4). 682–692. 6 indexed citations

Li, Jiangtao, Dong Zhao, Qiuju Deng, et al.. (2022). Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study. Frontiers in Endocrinology. 13. 973078–973078. 2 indexed citations

10.

Yang, Lijiao, Nan Ye, Guoqin Wang, et al.. (2021). The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project. BMC Cardiovascular Disorders. 21(1). 345–345. 2 indexed citations

11.

Li, Ziping, Pengfei Yang, Haonan Sun, et al.. (2021). Early Guideline-Directed Medical Therapy and in-Hospital Major Bleeding Risk in ST-Elevation Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Findings from the CCC-ACS Project. Cardiovascular Drugs and Therapy. 37(1). 117–127. 1 indexed citations

12.

Hu, Guoliang, Mengge Zhou, Jing Liu, et al.. (2020). Smoking and Provision of Smoking Cessation Interventions among Inpatients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Global Heart. 15(1). 72–72. 13 indexed citations

13.

Fan, Fangfang, Yuxi Li, Yan Zhang, et al.. (2019). Chest Pain Center Accreditation Is Associated With Improved In‐Hospital Outcomes of Acute Myocardial Infarction Patients in China: Findings From the CCC‐ACS Project. Journal of the American Heart Association. 8(21). e013384–e013384. 38 indexed citations

14.

Yang, Na, Jing Liu, Jun Liu, et al.. (2019). Performance on management strategies with Class I Recommendation and A Level of Evidence among hospitalized patients with non–ST-segment elevation acute coronary syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China–Acute Coronary Syndrome (CCC-ACS) project. American Heart Journal. 212. 80–90. 9 indexed citations

15.

Hao, Yongchen, Jing Liu, Sidney C. Smith, et al.. (2018). Rationale and design of the improving Care for Cardiovascular Disease in China (CCC) project: a national registry to improve management of atrial fibrillation. BMJ Open. 8(7). e020968–e020968. 14 indexed citations

16.

Qi, Yue, Xueyu Han, Dong Zhao, et al.. (2018). Long-Term Cardiovascular Risk Associated With Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline. Journal of the American College of Cardiology. 72(11). 1201–1210. 102 indexed citations

17.

Zhang, Xingguang, Jing Liu, Miao Wang, et al.. (2018). Twenty-year epidemiologic study on LDL-C levels in relation to the risks of atherosclerotic event, hemorrhagic stroke, and cancer death among young and middle-aged population in China. Journal of clinical lipidology. 12(5). 1179–1189.e4. 34 indexed citations

18.

Hao, Yongchen, Jing Liu, Jun Liu, & Dong Zhao. (2017). GW28-e0889 In-hospital Outcomes of Acute Coronary Syndrome Patients With Diabetes Mellitus: A Report From the Improving Care for Cardiovascular Disease in China Project. Journal of the American College of Cardiology. 70(16). C99–C100. 1 indexed citations

19.

Zhao, Fan, Yue Qi, Jing Liu, et al.. (2017). Low Very low-Density Lipoprotein Cholesterol but High Very low-Density Lipoprotein Receptor mRNA Expression in Peripheral White Blood Cells: An Atherogenic Phenotype for Atherosclerosis in a Community-Based Population. EBioMedicine. 25. 136–142. 11 indexed citations

20.

Zhou, Mengge, Jing Liu, Yue Qi, et al.. (2017). The association between Helicobacter pylori seropositivity and risk of new-onset diabetes: a prospective cohort study. Diabetologia. 61(2). 300–307. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact